FASEB bioAdvances最新文献

筛选
英文 中文
Healthcare is not about health 医疗保健与健康无关
IF 2.7
FASEB bioAdvances Pub Date : 2023-04-25 DOI: 10.1096/fba.2023-00007
James O. Woolliscroft, Larry D. Gruppen, Jasna Markovac, Edward F. Meehan
{"title":"Healthcare is not about health","authors":"James O. Woolliscroft,&nbsp;Larry D. Gruppen,&nbsp;Jasna Markovac,&nbsp;Edward F. Meehan","doi":"10.1096/fba.2023-00007","DOIUrl":"10.1096/fba.2023-00007","url":null,"abstract":"<p>Initiatives designed to reduce the disease burden and improve the health of the US population that focus on increasing access to health care have been disappointing. Progress requires multifaceted change. We must first acknowledge that the healthcare system is focused on reversing or modifying disease, not enhancing health. Our conceptualization of the development of ill health and disease must also change. Scientific advances are clarifying the complex interactions among the development of ill health and disease and an individual's behaviors, their microbiota, and their physical, social, and emotional environments. A person's genetic makeup predisposes them to a wide array of disease conditions but is rarely deterministic in and of itself. Factors extrinsic to the individual, including the social determinants of health, play a major role in disease development, often decades later. The complexity of health and disease requires a “team” accountable for the health of our populations, and these teams must be expanded beyond the medical professions. Governmental officials, architects, business leaders, civic organizations, social and neighborhood groups are among the key stakeholders on the health side of the equation. If and when disease does become manifest, then the care part of the healthcare system assumes the larger role. This has major implications for the education of our clinically focused health science students, but also of professional disciplines previously deemed peripheral to health. Simply redoubling our efforts and focusing on our current healthcare system is insufficient to make progress in the health of the populace. One example of a multipronged approach in Allentown, PA is explored in depth.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"5 6","pages":"221-227"},"PeriodicalIF":2.7,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1b/6a/FBA2-5-221.PMC10242194.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9599237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Local fat content determines global and local stiffness in livers with simple steatosis 局部脂肪含量决定了单纯性脂肪变性患者肝脏的整体和局部硬度
IF 2.7
FASEB bioAdvances Pub Date : 2023-04-24 DOI: 10.1096/fba.2022-00134
David Li, Paul A. Janmey, Rebecca G. Wells
{"title":"Local fat content determines global and local stiffness in livers with simple steatosis","authors":"David Li,&nbsp;Paul A. Janmey,&nbsp;Rebecca G. Wells","doi":"10.1096/fba.2022-00134","DOIUrl":"10.1096/fba.2022-00134","url":null,"abstract":"<p>Fat accumulation during liver steatosis precedes inflammation and fibrosis in fatty liver diseases, and is associated with disease progression. Despite a large body of evidence that liver mechanics play a major role in liver disease progression, the effect of fat accumulation by itself on liver mechanics remains unclear. Thus, we conducted ex vivo studies of liver mechanics in rodent models of simple steatosis to isolate and examine the mechanical effects of intrahepatic fat accumulation, and found that fat accumulation softens the liver. Using a novel adaptation of microindentation to permit association of local mechanics with microarchitectural features, we found evidence that the softening of fatty liver results from local softening of fatty regions rather than uniform softening of the liver. These results suggest that fat accumulation itself exerts a softening effect on liver tissue. This, along with the localized heterogeneity of softening within the liver, has implications in what mechanical mechanisms are involved in the progression of liver steatosis to more severe pathologies and disease. Finally, the ability to examine and associate local mechanics with microarchitectural features is potentially applicable to the study of the role of heterogeneous mechanical microenvironments in both other liver pathologies and other organ systems.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"5 6","pages":"251-261"},"PeriodicalIF":2.7,"publicationDate":"2023-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ef/23/FBA2-5-251.PMC10242205.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10093838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GPX2 promotes EMT and metastasis in non-small cell lung cancer by activating PI3K/AKT/mTOR/Snail signaling axis GPX2通过激活PI3K/AKT/mTOR/Snail信号轴促进非小细胞肺癌的EMT和转移
IF 2.7
FASEB bioAdvances Pub Date : 2023-03-05 DOI: 10.1096/fba.2022-00045
Fang Peng, Qiushi Xu, Xiaomeng Jing, Xinming Chi, Zheming Zhang, Xiangpeng Meng, Xinyuan Liu, Jiao Yan, Xuefeng Liu, Shujuan Shao
{"title":"GPX2 promotes EMT and metastasis in non-small cell lung cancer by activating PI3K/AKT/mTOR/Snail signaling axis","authors":"Fang Peng,&nbsp;Qiushi Xu,&nbsp;Xiaomeng Jing,&nbsp;Xinming Chi,&nbsp;Zheming Zhang,&nbsp;Xiangpeng Meng,&nbsp;Xinyuan Liu,&nbsp;Jiao Yan,&nbsp;Xuefeng Liu,&nbsp;Shujuan Shao","doi":"10.1096/fba.2022-00045","DOIUrl":"10.1096/fba.2022-00045","url":null,"abstract":"<p>Lung cancer, with non-small cell lung cancer (NSCLC) being the main subtype, is the leading cause of cancer death worldwide, which is mainly due to the cancer metastasis. Glutathione peroxidase 2 (GPX2), an antioxidant enzyme, is involved in tumor progression and metastasis. Nevertheless, the role of GPX2 in NSCLC metastasis has not been clarified. In this study, we found that GPX2 expression was elevated in NSCLC tissues and high GPX2 expression was correlated with poor prognosis in patients with NSCLC. In addtion, GPX2 expression was related to the patient's clinicopathological features, including lymph node metastasis, tumor size, and TNM stage. Overexpression of GPX2 promoted epithelial–mesenchymal transition (EMT), migration, and invasion of NSCLC cells in vitro. Knockdown of GPX2 showed the opposite effects in vitro and inhibited the metastasis of NSCLC cells in nude mice. Furthermore, GPX2 reduced reactive oxygen species (ROS) accumulation and activated the PI3K/AKT/mTOR/Snail signaling axis. Therefore, our results indicate that GPX2 promotes EMT and metastasis of NSCLC cells by activating the PI3K/AKT/mTOR/Snail signaling axis via the removal of ROS. GPX2 may be an effective diagnostic and prognostic biomarker for NSCLC.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"5 6","pages":"233-250"},"PeriodicalIF":2.7,"publicationDate":"2023-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ed/d9/FBA2-5-233.PMC10242197.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9971674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy 靶向XBP1 mRNA剪接使胶质母细胞瘤对化疗增敏
IF 2.7
FASEB bioAdvances Pub Date : 2023-02-24 DOI: 10.1096/fba.2022-00141
Amiee Dowdell, Mark Marsland, Sam Faulkner, Craig Gedye, James Lynam, Cassandra P. Griffin, Joanne Marsland, Chen Chen Jiang, Hubert Hondermarck
{"title":"Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy","authors":"Amiee Dowdell,&nbsp;Mark Marsland,&nbsp;Sam Faulkner,&nbsp;Craig Gedye,&nbsp;James Lynam,&nbsp;Cassandra P. Griffin,&nbsp;Joanne Marsland,&nbsp;Chen Chen Jiang,&nbsp;Hubert Hondermarck","doi":"10.1096/fba.2022-00141","DOIUrl":"10.1096/fba.2022-00141","url":null,"abstract":"<p>Glioblastoma (GBM) is the most frequent and deadly primary brain tumor in adults. Temozolomide (TMZ) is the standard systemic therapy in GBM but has limited and restricted efficacy. Better treatments are urgently needed. The role of endoplasmic reticulum stress (ER stress) is increasingly described in GBM pathophysiology. A key molecular mediator of ER stress, the spliced form of the transcription factor x-box binding protein 1 (XBP1s) may constitute a novel therapeutic target; here we report XBP1s expression and biological activity in GBM. Tumor samples from patients with GBM (<i>n</i> = 85) and low-grade glioma (<i>n</i> = 20) were analyzed by immunohistochemistry for XBP1s with digital quantification. XBP1s expression was significantly increased in GBM compared to low-grade gliomas. XBP1s mRNA showed upregulation by qPCR analysis in a panel of patient-derived GBM cell lines. Inhibition of XBP1 splicing using the small molecular inhibitor MKC-3946 significantly reduced GBM cell viability and potentiated the effect of TMZ in GBM cells, particularly in those with methylated O<sup>6</sup>-methylguanine-DNA methyl transferase gene promoter. GBM cells resistant to TMZ were also responsive to MKC-3946 and the long-term inhibitory effect of MKC-3946 was confirmed by colony formation assay. In conclusion, this data reveals that XBP1s is overexpressed in GBM and contributes to cancer cell growth. XBP1s warrants further investigation as a clinical biomarker and therapeutic target in GBM.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"5 5","pages":"211-220"},"PeriodicalIF":2.7,"publicationDate":"2023-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/37/53/FBA2-5-211.PMC10158625.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9430164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression rna结合蛋白Snd1/Tudor-SN调节缺氧反应基因的表达
IF 2.7
FASEB bioAdvances Pub Date : 2023-02-12 DOI: 10.1096/fba.2022-00115
Juha Saarikettu, Saara Lehmusvaara, Marko Pesu, Ilkka Junttila, Juha Partanen, Petra Sipilä, Matti Poutanen, Jie Yang, Teemu Haikarainen, Olli Silvennoinen
{"title":"The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression","authors":"Juha Saarikettu,&nbsp;Saara Lehmusvaara,&nbsp;Marko Pesu,&nbsp;Ilkka Junttila,&nbsp;Juha Partanen,&nbsp;Petra Sipilä,&nbsp;Matti Poutanen,&nbsp;Jie Yang,&nbsp;Teemu Haikarainen,&nbsp;Olli Silvennoinen","doi":"10.1096/fba.2022-00115","DOIUrl":"10.1096/fba.2022-00115","url":null,"abstract":"<p>Snd1 is an evolutionarily conserved RNA-binding protein implicated in several regulatory processes in gene expression including activation of transcription, mRNA splicing, and microRNA decay. Here, we have investigated the outcome of <i>Snd1</i> gene deletion in the mouse. The knockout mice are viable showing no gross abnormalities apart from decreased fertility, organ and body size, and decreased number of myeloid cells concomitant with decreased expression of granule protein genes. Deletion of <i>Snd1</i> affected the expression of relatively small number of genes in spleen and liver. However, mRNA expression changes in the knockout mouse liver showed high similarity to expression profile in adaptation to hypoxia. MicroRNA expression in liver showed upregulation of the hypoxia-induced microRNAs miR-96 and -182. Similar to Snd1 deletion, mimics of miR-96/182 enhanced hypoxia-responsive reporter activity. To further elucidate the function of SND1, BioID biotin proximity ligation assay was performed in HEK-293T cells to identify interacting proteins. Over 50% of the identified interactors were RNA-binding proteins, including stress granule proteins. Taken together, our results show that in normal growth conditions, Snd1 is not a critical factor for mRNA transcription in the mouse, and describe a function for Snd1 in hypoxia adaptation through negatively regulating hypoxia-related miRNAs and hypoxia-induced transcription consistent with a role as stress response regulator.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"5 5","pages":"183-198"},"PeriodicalIF":2.7,"publicationDate":"2023-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://faseb.onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2022-00115","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9423029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Intestinal barrier dysfunction in murine sickle cell disease is associated with small intestine neutrophilic inflammation, oxidative stress, and dysbiosis 小鼠镰状细胞病的肠道屏障功能障碍与小肠中性粒细胞炎症、氧化应激和生态失调有关
IF 2.7
FASEB bioAdvances Pub Date : 2023-02-12 DOI: 10.1096/fba.2022-00121
Caitlin V. Lewis, Hassan Sellak, Mariem A. Sawan, Giji Joseph, Trevor M. Darby, David VanInsberghe, Crystal R. Naudin, David R. Archer, Rheinallt M. Jones, W. Robert Taylor
{"title":"Intestinal barrier dysfunction in murine sickle cell disease is associated with small intestine neutrophilic inflammation, oxidative stress, and dysbiosis","authors":"Caitlin V. Lewis,&nbsp;Hassan Sellak,&nbsp;Mariem A. Sawan,&nbsp;Giji Joseph,&nbsp;Trevor M. Darby,&nbsp;David VanInsberghe,&nbsp;Crystal R. Naudin,&nbsp;David R. Archer,&nbsp;Rheinallt M. Jones,&nbsp;W. Robert Taylor","doi":"10.1096/fba.2022-00121","DOIUrl":"10.1096/fba.2022-00121","url":null,"abstract":"<p>The intestinal microbiome has emerged as a potential contributor to the severity of sickle cell disease (SCD). We sought to determine whether SCD mice exhibit intestinal barrier dysfunction, inflammation, and dysbiosis. Using the Townes humanized sickle cell mouse model, we found a 3-fold increase in intestinal permeability as assessed via FITC-dextran (4 kDa) assay in SS (SCD) mice compared to AA (wild type) mice (<i>n</i> = 4, <i>p</i> &lt; 0.05). This was associated with 25 to 50% decreases in claudin-1, 3, and 15 and zonula occludens-1 gene expression (<i>n</i> = 8–10, <i>p</i> &lt; 0.05) in the small intestine. Increased Ly6G staining demonstrated more neutrophils in the SS small intestine (3-fold, <i>n</i> = 5, <i>p</i> &lt; 0.05) associated with increased expression of TNFα, IL-17A, CXCL1, and CD68 (2.5 to 5-fold, <i>n</i> = 7–10, <i>p</i> &lt; 0.05). In addition, we observed 30 to 55% decreases in superoxide dismutase-1, glutathione peroxidase-1, and catalase antioxidant enzyme expression (<i>n</i> = 7–8, <i>p</i> &lt; 0.05) concomitant to an increase in superoxide (2-fold, <i>n</i> = 4, <i>p</i> &lt; 0.05). Importantly, all significant observations of a leaky gut phenotype and inflammation were limited to the small intestine and not observed in the colon. Finally, characterization of the composition of the microbiome within the small intestine revealed dysbiosis in SS mice compared to their AA littermates with 47 phyla to species-level significant alterations in amplicon sequence variants. We conclude that the intestinal barrier is compromised in SCD, associated with decreased gene expression of tight junction proteins, enhanced inflammation, oxidative stress, and gut microbiome dysbiosis, all specific to the small intestine.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"5 5","pages":"199-210"},"PeriodicalIF":2.7,"publicationDate":"2023-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e8/e6/FBA2-5-199.PMC10158626.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9423030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxidative stress induces MUC5AC expression through mitochondrial damage-dependent STING signaling in human bronchial epithelial cells 氧化应激通过线粒体损伤依赖性STING信号诱导人支气管上皮细胞MUC5AC表达
IF 2.7
FASEB bioAdvances Pub Date : 2023-02-01 DOI: 10.1096/fba.2022-00081
Yutaka Nishida, Hisako Yagi, Masaya Ota, Atsushi Tanaka, Koichiro Sato, Takaharu Inoue, Satoshi Yamada, Naoya Arakawa, Takashi Ishige, Yasuko Kobayashi, Hirokazu Arakawa, Takumi Takizawa
{"title":"Oxidative stress induces MUC5AC expression through mitochondrial damage-dependent STING signaling in human bronchial epithelial cells","authors":"Yutaka Nishida,&nbsp;Hisako Yagi,&nbsp;Masaya Ota,&nbsp;Atsushi Tanaka,&nbsp;Koichiro Sato,&nbsp;Takaharu Inoue,&nbsp;Satoshi Yamada,&nbsp;Naoya Arakawa,&nbsp;Takashi Ishige,&nbsp;Yasuko Kobayashi,&nbsp;Hirokazu Arakawa,&nbsp;Takumi Takizawa","doi":"10.1096/fba.2022-00081","DOIUrl":"https://doi.org/10.1096/fba.2022-00081","url":null,"abstract":"<p>Oxidative stress increases the production of the predominant mucin MUC5AC in airway epithelial cells and is implicated in the pathogenesis of bronchial asthma and chronic obstructive pulmonary disease. Oxidative stress impairs mitochondria, releasing mitochondrial DNA into the cytoplasm and inducing inflammation through the intracytoplasmic DNA sensor STING (stimulator of interferon genes). However, the role of innate immunity in mucin production remains unknown. We aimed to elucidate the role of innate immunity in mucin production in airway epithelial cells under oxidative stress. Human airway epithelial cell line (NCI-H292) and normal human bronchial epithelial cells were used to confirm <i>MUC5AC</i> expression levels by real-time PCR when stimulated with hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). <i>MUC5AC</i> transcriptional activity was increased and mitochondrial DNA was released into the cytosol by H<sub>2</sub>O<sub>2</sub>. Mitochondrial antioxidants were used to confirm the effects of mitochondrial oxidative stress where antioxidants inhibited the increase in <i>MUC5AC</i> transcriptional activity. Cyclic GMP-AMP synthase (cGAS) or STING knockout (KO) cells were generated to investigate their involvement. H<sub>2</sub>O<sub>2</sub>-induced <i>MUC5AC</i> expression was suppressed in STING KO cells, but not in cGAS KO cells. The epidermal growth factor receptor was comparably expressed in STING KO and wild-type cells. Thus, mitochondria and STING play important roles in mucin production in response to oxidative stress in airway epithelial cells.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"5 4","pages":"171-181"},"PeriodicalIF":2.7,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1096/fba.2022-00081","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50116087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
B cell-dependent subtypes and treatment-based immune correlates to survival in stage 3 and 4 lung adenocarcinomas B细胞依赖亚型和基于治疗的免疫与3期和4期肺腺癌的生存相关
IF 2.7
FASEB bioAdvances Pub Date : 2023-01-28 DOI: 10.1096/fba.2023-00009
Susan Raju Paul, Ivan Valiev, Skylar E. Korek, Vladimir Zyrin, Diana Shamsutdinova, Olga Gancharova, Alexander Zaitsev, Ekaterina Nuzhdina, Diane L. Davies, Ibiayi Dagogo-Jack, Felix Frenkel, Jessica H. Brown, Joshua M. Hess, Sarah Viet, Jason L. Petersen, Cameron D. Wright, Harald C. Ott, Hugh G. Auchincloss, Ashok Muniappan, Toshihiro Shioda, Michael Lanuti, Christel M. Davis, Erik A. Ehli, Yin P. Hung, Mari Mino-Kenudson, Maria Tsiper, Ann E. Sluder, Patrick M. Reeves, Nikita Kotlov, Alexander Bagaev, Ravshan Ataullakhanov, Mark C. Poznansky
{"title":"B cell-dependent subtypes and treatment-based immune correlates to survival in stage 3 and 4 lung adenocarcinomas","authors":"Susan Raju Paul,&nbsp;Ivan Valiev,&nbsp;Skylar E. Korek,&nbsp;Vladimir Zyrin,&nbsp;Diana Shamsutdinova,&nbsp;Olga Gancharova,&nbsp;Alexander Zaitsev,&nbsp;Ekaterina Nuzhdina,&nbsp;Diane L. Davies,&nbsp;Ibiayi Dagogo-Jack,&nbsp;Felix Frenkel,&nbsp;Jessica H. Brown,&nbsp;Joshua M. Hess,&nbsp;Sarah Viet,&nbsp;Jason L. Petersen,&nbsp;Cameron D. Wright,&nbsp;Harald C. Ott,&nbsp;Hugh G. Auchincloss,&nbsp;Ashok Muniappan,&nbsp;Toshihiro Shioda,&nbsp;Michael Lanuti,&nbsp;Christel M. Davis,&nbsp;Erik A. Ehli,&nbsp;Yin P. Hung,&nbsp;Mari Mino-Kenudson,&nbsp;Maria Tsiper,&nbsp;Ann E. Sluder,&nbsp;Patrick M. Reeves,&nbsp;Nikita Kotlov,&nbsp;Alexander Bagaev,&nbsp;Ravshan Ataullakhanov,&nbsp;Mark C. Poznansky","doi":"10.1096/fba.2023-00009","DOIUrl":"10.1096/fba.2023-00009","url":null,"abstract":"<p>Lung cancer is the leading cause of cancer-related deaths worldwide. Surgery and chemoradiation are the standard of care in early stages of non-small cell lung cancer (NSCLC), while immunotherapy is the standard of care in late-stage NSCLC. The immune composition of the tumor microenvironment (TME) is recognized as an indicator for responsiveness to immunotherapy, although much remains unknown about its role in responsiveness to surgery or chemoradiation. In this pilot study, we characterized the NSCLC TME using mass cytometry (CyTOF) and bulk RNA sequencing (RNA-Seq) with deconvolution of RNA-Seq being performed by Kassandra, a recently published deconvolution tool. Stratification of patients based on the intratumoral abundance of B cells identified that the B-cell rich patient group had increased expression of CXCL13 and greater abundance of PD1<sup>+</sup> CD8 T cells. The presence of B cells and PD1<sup>+</sup> CD8 T cells correlated positively with the presence of intratumoral tertiary lymphoid structures (TLS). We then assessed the predictive and prognostic utility of these cell types and TLS within publicly available stage 3 and 4 lung adenocarcinoma (LUAD) RNA-Seq datasets. As previously described by others, pre-treatment expression of intratumoral 12-chemokine TLS gene signature is associated with progression free survival (PFS) in patients who receive treatment with immune checkpoint inhibitors (ICI). Notably and unexpectedly pre-treatment percentages of intratumoral B cells are associated with PFS in patients who receive surgery, chemotherapy, or radiation. Further studies to confirm these findings would allow for more effective patient selection for both ICI and non-ICI treatments.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"5 4","pages":"156-170"},"PeriodicalIF":2.7,"publicationDate":"2023-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ed/74/FBA2-5-156.PMC10068771.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9250895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research productivity and training support for doctoral students in the biological and biomedical sciences 为生物和生物医学领域的博士生提供研究生产力和培训支持
IF 2.7
FASEB bioAdvances Pub Date : 2023-01-27 DOI: 10.1096/fba.2022-00117
Michael D. Schaller
{"title":"Research productivity and training support for doctoral students in the biological and biomedical sciences","authors":"Michael D. Schaller","doi":"10.1096/fba.2022-00117","DOIUrl":"10.1096/fba.2022-00117","url":null,"abstract":"<p>Training of doctoral students as part of the next generation of the biomedical workforce is essential for sustaining the scientific enterprise in the United States. Training primarily occurs at institutions of higher education, and these trainees comprise an important part of the workforce at these institutions. Federal investment in the support of doctoral students in the biological and biomedical sciences is distributed differently than the distribution of students across different types of institutions, for example, public vs private. Institutions in states that historically receive less federal support for research also receive less support for doctoral student training. Doctorates at different types of institution exhibit little difference in research productivity, with the exception of citations, and subsequent receipt of additional NIH awards. Thus, training outcomes, which are related to the quality of the student and training environment, are similar across different institutions. Research productivity of doctoral students does not correlate with the number of F31s awarded to an institution. Factors that correlate with F31 funding include R01 funding levels and program size. The findings suggest strategies for institutions to increase success at securing F31s and modification of policy to promote more equitable distribution of F31s across institutions.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"5 3","pages":"131-148"},"PeriodicalIF":2.7,"publicationDate":"2023-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/12/11/FBA2-5-131.PMC9983073.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10849731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Erratum to “The roles of HMGB1-produced DNA gaps in DNA protection and aging biomarker reversal” 对“hmgb1产生的DNA缺口在DNA保护和衰老生物标志物逆转中的作用”的勘误
IF 2.7
FASEB bioAdvances Pub Date : 2023-01-25 DOI: 10.1096/fba.1365
{"title":"Erratum to “The roles of HMGB1-produced DNA gaps in DNA protection and aging biomarker reversal”","authors":"","doi":"10.1096/fba.1365","DOIUrl":"10.1096/fba.1365","url":null,"abstract":"<p>This erratum corrects the following:</p><p>Yasom, S., Watcharanurak, P., Bhummaphan, N., Thongsroy, J., Puttipanyalears, C., Settayanon, S., Chalertpet, K., Khumsri, W., Kongkaew, A., Patchsung, M., Siriwattanakankul, C., Pongpanich, M., Pin-on, P., Jindatip, D., Wanotayan, R., Odton, M., Supasai, S., Oo, T. T., Arunsak, B., Pratchayasakul, W., Chattipakorn, N., Chattipakorn, S., Mutirangura, A. (First published March 9, 2022) The roles of HMGB1-produced DNA gaps in DNA protection and aging biomarker reversal. <i>FASEB BioAdvances</i>. 2022;4:408–434. doi: 10.1096/fba.2021-00131</p><p>The authors report that inadvertent errors were made in assembling two of the figures submitted for publication. In both Figures 8 and 9, the left-hand row labels “Liver 1” to “Liver 4” are misleading and should not have been inserted. In Figure 8, the images in the 7m PC column should be the same as those shown in the 7m PC column in Figure 9, as the same group of rats is represented in both figures. In Figure 9, a different view of the image in row two of the 30m PC column was inadvertently placed in row four of the 30m PC column. The authors apologize for these oversights and for any confusion caused by the errors. These errors do not affect the results and conclusions reported in the article.</p><p>The correct versions of Figures 8 and 9 are as follows:</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"5 2","pages":"85-87"},"PeriodicalIF":2.7,"publicationDate":"2023-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://faseb.onlinelibrary.wiley.com/doi/epdf/10.1096/fba.1365","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10767158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信